All In Biotech

Drug Trial Radar · NCT03322462

Tau Screening Study in Patients With Early Symptomatic AD

A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD

Last checked: Nov 20, 2026Latest source record: Aug 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

155

Actual

Start

Nov 21, 2017

Primary completion

Aug 31, 2018

Study completion Aug 31, 2018

Sponsor

Lead sponsor
Avid RadiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Oct 26, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This protocol is designed to serve as a pre-screening study for subjects who are potentially eligible for Alzheimer's Disease (AD) therapeutic trials that require tau imaging for inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.

Conditions

  • Alzheimer Disease

Interventions

  • Flortaucipir F18Drug

    370 megabecquerel (MBq) IV single-dose

  • Brain PET ScanProcedure

    positron emission tomography (PET) scan of the brain

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Flortaucipir Qualitative Results (Visual Reads)Time frame: baseline scan
  2. Flortaucipir Quantitative Results (SUVr)Time frame: baseline scan

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Pacific Research Network

    San Diego, California

  • Syrentis Clinical Research

    Santa Ana, California

  • Brain Matters Research

    Delray Beach, Florida

  • Bioclinica (Compass Research)

    Orlando, Florida

  • Axiom Clinical Research

    Tampa, Florida

  • Boston Center for Memory

    Newton, Massachusetts

  • PMG Research

    Winston-Salem, North Carolina

  • Abington Neurological Associates

    Willow Grove, Pennsylvania

  • The Memory Clinic

    Bennington, Vermont

  • Toronto Memory Program

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.